Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors
As set out in paragraph C.05.010(b) of the Food and Drug Regulations (FDR), clinical trials must follow certain requirements of the protocol. Health Canada authorizes this protocol and the Research Ethics Board approves it. During the pandemic, there may be more deviations from the established protocol.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsorsHTMLEnglish publication HTML
Similar records